Bill 118 hr 8725, also known as the Increasing Medication Access for Seniors Act of 2024, aims to improve access to affordable prescription medications for senior citizens in the United States. The bill was introduced in the House of Representatives in response to concerns about rising drug prices and the financial burden this places on older Americans.
The key provisions of the bill include:
1. Allowing Medicare to negotiate drug prices with pharmaceutical companies: Currently, Medicare is prohibited from negotiating directly with drug manufacturers for lower prices. This bill would change that, allowing Medicare to use its purchasing power to negotiate better deals for prescription medications.
2. Expanding access to generic drugs: The bill includes measures to encourage the development and availability of generic versions of brand-name drugs. This would help lower costs for seniors by providing more affordable alternatives to expensive brand-name medications.
3. Increasing transparency in drug pricing: The bill requires pharmaceutical companies to disclose information about the costs of producing and marketing their drugs. This transparency would help identify instances of price gouging and hold drug manufacturers accountable for their pricing practices.
4. Providing financial assistance for low-income seniors: The bill includes provisions to help low-income seniors afford their medications, such as expanding eligibility for Medicare's Extra Help program and increasing funding for prescription drug assistance programs.
Overall, the Increasing Medication Access for Seniors Act of 2024 aims to address the challenges that many seniors face in accessing affordable prescription medications. By allowing Medicare to negotiate drug prices, expanding access to generic drugs, increasing transparency in drug pricing, and providing financial assistance for low-income seniors, the bill seeks to make prescription medications more affordable and accessible for older Americans.